Meyka AI API is live for developers.Start building.
Advertisement
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) Stock Overview

Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

DGX●NYSE
HealthcareMedical - Diagnostics & Research
$207.49
$4.38(2.15%)
U.S. Market is Open · 11:09
Advertisement

Quest Diagnostics Incorporated (DGX)

Meyka AI Score

Z

Key Financials

Market Cap22.9B
P/E Ratio22.44
EPS (TTM)$10.14
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$185.58
3 Months$207.38
1 Year Target$222.07

DGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $222.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.44 and a market capitalization of 22.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.68%
5-Day Change
6.39%
1-Month Change
7.08%
3-Month Change
5.13%
6-Month Change
17.39%
Year-to-Date (YTD) Change
19.02%
1-Year Change
15.61%
3-Year Change
46.07%
5-Year Change
59.32%
All-Time (Max) Change
5800.86%

Contact Information

https://www.questdiagnostics.com
973 520 2700
500 Plaza Drive, Secaucus, NJ, 07094

Company Facts

550,000 Employees
IPO DateDec 17, 1996
CountryUS
Actively Trading

Frequently Asked Questions